Principal Financial Group Inc Adaptive Biotechnologies Corp Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$2.34 - $3.96 $35,121 - $59,435	-15,009 Reduced 46.18%	17,495 $63,000
Q1 2024 Apr 29, 2024	SELL	$2.88 - $4.8 $1.32 Million - $2.21 Million	-459,615 Reduced 93.4%	32,504 $104,000
Q4 2023 Feb 07, 2024	SELL	$3.46 - $5.33 $2.61 Million - $4.02 Million	-754,745 Reduced 60.53%	492,119 $2.41 Million
Q3 2023 Nov 02, 2023	SELL	$5.07 - $8.44 $41,873 - $69,705	-8,259 Reduced 0.66%	1,246,864 $6.8 Million
Q2 2023 Aug 07, 2023	BUY	$6.19 - $8.78 $49,470 - $70,169	7,992 Added 0.64%	1,255,123 $8.42 Million
Q1 2023 May 09, 2023	SELL	$7.8 - $10.11 $76,284 - $98,875	-9,780 Reduced 0.78%	1,247,131 $11 Million
Q4 2022 Feb 09, 2023	SELL	$6.26 - $9.34 $359,123 - $535,817	-57,368 Reduced 4.36%	1,256,911 $9.6 Million
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $735,910 - $1.43 Million	113,217 Added 9.43%	1,314,279 $9.36 Million
Q2 2022 Aug 10, 2022	BUY	$6.4 - $14.73 $4.39 Million - $10.1 Million	685,171 Added 132.81%	1,201,062 $9.72 Million
Q1 2022 May 09, 2022	BUY	$10.12 - $28.9 $344,727 - $984,449	34,064 Added 7.07%	515,891 $7.16 Million
Q4 2021 Feb 09, 2022	BUY	$25.17 - $36.85 $202,845 - $296,974	8,059 Added 1.7%	481,827 $13.5 Million
Q3 2021 Nov 09, 2021	BUY	$30.02 - $39.87 $362,011 - $480,792	12,059 Added 2.61%	473,768 $16.1 Million
Q2 2021 Aug 10, 2021	BUY	$32.22 - $44.59 $3.52 Million - $4.88 Million	109,380 Added 31.04%	461,709 $18.9 Million
Q1 2021 May 10, 2021	BUY	$37.26 - $67.74 $1.08 Million - $1.97 Million	29,042 Added 8.98%	352,329 $14.2 Million
Q4 2020 Feb 08, 2021	BUY	$45.01 - $65.47 $279,647 - $406,765	6,213 Added 1.96%	323,287 $19.1 Million
Q3 2020 Nov 06, 2020	BUY	$35.79 - $48.81 $3.9 Million - $5.32 Million	109,027 Added 52.4%	317,074 $15.4 Million
Q2 2020 Aug 05, 2020	BUY	$24.95 - $48.38 $3.47 Million - $6.72 Million	138,977 Added 201.21%	208,047 $10.1 Million
Q1 2020 May 12, 2020	SELL	$16.96 - $34.16 $81,408 - $163,967	-4,800 Reduced 6.5%	69,070 $1.92 Million
Q4 2019 Feb 05, 2020	BUY	$24.56 - $32.8 $91,928 - $122,770	3,743 Added 5.34%	73,870 $2.21 Million
Q3 2019 Nov 13, 2019	SELL	$30.31 - $53.51 $299,250 - $528,304	-9,873 Reduced 12.34%	70,127 $2.17 Million
Q2 2019 Aug 12, 2019	BUY	$40.3 - $48.3 $3.22 Million - $3.86 Million	80,000 New	80,000 $3.86 Million

Others Institutions Holding ADPT

# of Institutions

205

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$240 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$115 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$93.4 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$92.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$85.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.14B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account